Leadership Team

Scott leads Eagle with more than 25 years of industry experience. Scott founded Eagle in 2007 with the objective of utilizing the 505(b)(2) pathway to maximize the potential of proven medicines. Prior to founding the company, Scott held several key executive-level positions at publicly traded

Brian was promoted to Chief Financial Officer at Eagle in October 2020, after serving as VP of Finance and Corporate Controller. Brian is a finance and accounting professional with more than 20 years of public company and public accounting experience.

Dan is our Executive Vice President of Biologics and Corporate Development. Dan served as Finance Director from 2011 to May 2013, and has held multiple roles at Eagle during his tenure. Prior to joining Eagle in 2007, Dan held a variety of management positions, such as Senior Analyst at Ethicon (a

Mike joined Eagle in January 2016 as Vice President, Sales and was promoted to Executive Vice President, Sales, Business Development and Government Affairs in August 2019. Mike has a lengthy record of success in the pharmaceutical industry. Prior to joining Eagle, Mike held various positions with

John joined Eagle in August 2020 as Executive Vice President, Marketing for Oncology and Acute Care. Prior to joining Eagle, he held an executive role at Celgene / Bristol Myers Squibb and spent 17 years in Marketing and Operations between Verizon and Vodafone.